DCP
DSM Capital Partners’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Buy |
+2,858
| New | +$307K | ﹤0.01% | 37 |
|
|
2024
Q4 | – | Sell |
-1,324
| Closed | -$111K | – | 52 |
|
|
2024
Q3 | $111K | Hold |
1,324
| – | – | ﹤0.01% | 46 |
|
|
2024
Q2 | $102K | Sell |
1,324
-2,167,681
| -100% | -$167M | ﹤0.01% | 45 |
|
|
2024
Q1 | $149M | Sell |
2,169,005
-669,618
| -24% | -$45.9M | 2.03% | 18 |
|
|
2023
Q4 | $164M | Buy |
2,838,623
+444,794
| +19% | +$25.7M | 2.51% | 14 |
|
|
2023
Q3 | $126M | Sell |
2,393,829
-96,116
| -4% | -$5.07M | 2.13% | 19 |
|
|
2023
Q2 | $135M | Sell |
2,489,945
-1,162,600
| -32% | -$62.9M | 2.18% | 17 |
|
|
2023
Q1 | $183M | Sell |
3,652,545
-1,347,768
| -27% | -$67.4M | 2.99% | 14 |
|
|
2022
Q4 | $231M | Sell |
5,000,313
-590,902
| -11% | -$27.3M | 3.85% | 10 |
|
|
2022
Q3 | $217M | Buy |
5,591,215
+294,050
| +6% | +$11.4M | 3.67% | 9 |
|
|
2022
Q2 | $197M | Buy |
5,297,165
+268,026
| +5% | +$9.99M | 3.31% | 8 |
|
|
2022
Q1 | $223M | Buy |
5,029,139
+1,174,491
| +30% | +$52M | 2.98% | 9 |
|
|
2021
Q4 | $164M | Sell |
3,854,648
-271,157
| -7% | -$11.5M | 1.72% | 19 |
|
|
2021
Q3 | $179M | Buy |
4,125,805
+501,060
| +14% | +$21.7M | 1.86% | 16 |
|
|
2021
Q2 | $155M | Buy |
3,624,745
+465,847
| +15% | +$19.9M | 1.49% | 24 |
|
|
2021
Q1 | $122M | Buy |
3,158,898
+167,679
| +6% | +$6.48M | 1.3% | 24 |
|
|
2020
Q4 | $108M | Buy |
2,991,219
+480,339
| +19% | +$17.3M | 1.15% | 24 |
|
|
2020
Q3 | $95.9M | Buy |
2,510,880
+447,561
| +22% | +$17.1M | 1.07% | 22 |
|
|
2020
Q2 | $72.4M | Sell |
2,063,319
-1,554,378
| -43% | -$54.6M | 0.86% | 26 |
|
|
2020
Q1 | $118M | Buy |
3,617,697
+1,335,632
| +59% | +$43.6M | 1.79% | 17 |
|
|
2019
Q4 | $103M | Buy |
+2,282,065
| New | +$103M | 1.37% | 25 |
|